AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2016
Jul 15, 2016
30826_dirs_2016-07-15_16348408-6675-45f1-ad6d-fefba87a3dd9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2016-07-14
Reporting Person: Snodgres Jon (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-14 | Common Stock | F | 324 | $26.56 | Disposed | 17453 | Direct |
Footnotes
F1: Payment of tax liability made via forfeiture of 324 shares of Common Stock valued at $26.56 per share, the closing price on July 13, 2016.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23